GENB peer analysis
Generate Biomedicines (GENB) against its competitors: price, today's move, 1-year return and market value side by side.
GENB and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABCL AbCellera | $11.66 | -2.43% | 194.51% | $3.86B |
| ABSI Absci | $9.32 | -7.91% | 181.45% | $1.67B |
| INBX Inhibrx Biosciences | $87.79 | -3.09% | 16.11% | $1.33B |
| STRO Sutro Biopharma | $9.54 | -7.02% | 14.50% | $154.37M |
| GENB Generate Biomedicines | $12.58 | -6.75% | – | $1.63B |
- GENB's peers: ABCL (AbCellera), ABSI (Absci), INBX (Inhibrx Biosciences), STRO (Sutro Biopharma).
Updated 2026-11-13 04:50 UTC